Chargement en cours...
Malignant peritoneal mesothelioma. Is there a new treatment?
The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
PAGEPress Publications
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2994480/ https://ncbi.nlm.nih.gov/pubmed/21139928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2009.e49 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|